Shop Research About Compliance Affiliate Free Consultation
HOT

Retatrutide + Cagrilintide

Reta-Cagri · Triple Agonist + Amylin Combination

Pre-mixed research blend combining retatrutide (GLP-1/GIP/glucagon triple agonist) with cagrilintide (amylin analog). Quadruple-pathway metabolic research.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Manufacturer Direct ✓ Direct Support
📋 Certificate of Analysis Request COA via Telegram
Select Size
per vial
+ $40 shipping · Free over $1,000 · ~2 week delivery
✓ Added to cart View Cart →
Research Data

What Is Retatrutide + Cagrilintide?

This blend combines retatrutide's triple agonism (GLP-1, GIP, glucagon) with cagrilintide's amylin receptor activity, creating a four-receptor pathway model. Research interest focuses on maximizing metabolic impact across satiety, energy expenditure, and hepatic fat pathways.

Research Context

  • Four-receptor pathway: GLP-1, GIP, GCG, amylin
  • Energy expenditure amplification via glucagon component
  • Hypothalamic satiety convergence model
  • Combination approach beyond current approved agents

Storage & Reconstitution

Store lyophilized at -20°C. Reconstitute with bacteriostatic water. Use within 28 days at 2–8°C.

All products sold for research purposes only. Not for human or animal consumption. Must be 18+ to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.